Stock BIOX BIOCERES CROP SOLUTIONS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Bioceres Crop Solutions Corp.

Equities

BIOX

KYG1117K1141

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
11.78 USD +4.06% Intraday chart for Bioceres Crop Solutions Corp. +7.58% -14.20%
May. 14 Transcript : Bioceres Crop Solutions Corp., Q3 2024 Earnings Call, May 14, 2024
May. 14 Bioceres Crop Solutions Fiscal Q3 Earnings, Revenue Fall MT

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • The firm trades with high earnings multiples: 36.81 times its 2024 earnings per share.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Agricultural Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
BIOCERES CROP SOLUTIONS CORP. Stock Bioceres Crop Solutions Corp.
-14.20% 740M -
CORTEVA, INC. Stock Corteva, Inc.
+16.74% 38.99B
C
PHOSAGRO Stock PhosAgro
-.--% 11.36B -
B+
FMC CORPORATION Stock FMC Corporation
-3.33% 7.61B
A
PI INDUSTRIES LIMITED Stock PI Industries Limited
+1.10% 6.45B
B-
ICL GROUP LTD Stock ICL Group Ltd
-2.37% 6.01B
B+
OCI N.V. Stock OCI N.V.
-4.50% 5.73B
B
YUNNAN YUNTIANHUA CO., LTD. Stock Yunnan Yuntianhua Co., Ltd.
+32.88% 5.25B
B-
THE FERTILISERS AND CHEMICALS TRAVANCORE LIMITED Stock The Fertilisers and Chemicals Travancore Limited
-16.30% 5.23B -
C-
UPL LIMITED Stock UPL Limited
-13.40% 4.58B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. BIOX Stock
  4. Ratings Bioceres Crop Solutions Corp.